- Home
- /
- Treatment
- /
- Page 26
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Exendin (9-39) | Noninsulinoma pancreatogenous hypoglycaemia syndrome | Eiger Biopharmaceuticals Europe Limited | October 14, 2016 | |
Fenretinide | T-cell lymphoma | Clinipace GmbH | October 14, 2016 | |
Human monoclonal IgG1 antibody against tissue factor pathway inhibitor | Haemophilia A | Pfizer Limited | October 14, 2016 | |
Haematopoietic stem cells modified with a lentiviral vector containing theCD18gene | Leukocyte adhesion deficiency type I | Consorcio Centro de Investigación Biomédica en Red M.P. | October 14, 2016 | |
(6aR,10aR)-3-(1′,1′-dimethylheptyl)-delta-8-tetrahydrocannabinol-9-carboxylic acid | Cystic fibrosis | TMC Pharma Services Ltd | October 14, 2016 | |
Lutetium-177(3+),S2,S7-cyclo[N-{4,7,10-tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl}-4-chloro-L-phenylalanyl-D-cysteinyl-4-[(4S)-2,6-dioxo-1,3-diazinane-4-carboxamido]-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-D-tyrosinamide] | Gastro-entero-pancreatic neuroendocrine tumours | Ipsen Pharma | October 14, 2016 | |
(E)-(6-((N-methyl-((3-methylbenzofuran-2-yl)methyl)amino)-3-oxoprop-1-en-1-yl)-2-oxo-3,4-dihydro-1,8-naphthyridin-1(2H)-yl)methyl phosphate, bis ethanolamine salt | Osteomyelitis | Voisin Consulting S.A.R.L. | October 14, 2016 | |
Vorinostat | Metastatic Melanoma | Qameleon Therapeutics;Moslaan 32, 1433 WJ;Kudelstaart | October 13, 2016 | |
Combination of an inactivated purified rabies virus (IPRV) and the PIKA adjuvant (Poly I:C, kanamycin and calcium) | Hepatocellular Carcinoma | Yisheng US Biopharma, Inc.;11 Firstfield Road, Suite A;Gaithersburg, Maryland, 20878 | October 13, 2016 | |
Atezolizumab | Small cell lung cancer (SCLC) | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | October 13, 2016 | |
Vibrio alginolyticus collagenase | Advanced Dupuytren's disease (Dupuytren's contracture) | Fidia Farmaceutici S.p.A.;Via Ponte della Fabbrica, 3/A;Abano Terme PD | October 12, 2016 | |
Ledipasvir/sofosbuvir | Chronic hepatitis C virus (HCV) infection in pediatric patients | Gilead Sciences, Inc.;333 Lakeside Drive;Foster City, California, 94404 | October 12, 2016 | |
Liposomal vinorelbine | Cutaneous T-cell lymphoma | Taiwan Liposome Company, Ltd.;11F-1, No. 3, Yuanqu Street;Taipei City | October 12, 2016 | |
Pembrolizumab | Nasopharyngeal carcinoma | Merck, Sharp & Dohme Corp., a subsidiary of Merck & Co.;1 Merck Drive;Whitehouse Station, New Jersey, 08889 | October 11, 2016 | |
Recombinant human monoclonal antibody against human complement component C5a | Graft Versus Host Disease | Alexion Pharmaceuticals, Inc.;100 College Street;New Haven, Connecticut, 06510 | October 6, 2016 | |
Ibudilast | Amyotrophic lateral sclerosis | MediciNova, Inc.;4275 Executive Square, Suite 650;La Jolla, California, 92037 | October 6, 2016 | |
Tacrolimus granules for oral suspension | Prevention of rejection in kidney, liver or heart transplant in pediatric patients | Astellas Pharma Global Development, Inc.;1 Astellas Way;Northbrook, Illinois, 60062 | October 4, 2016 | |
Autologous CD4+/CD8+ T cells expressing a CD19 chimeric antigen receptor (CAR) and a truncated epidermal growth factor receptor. | Chronic lymphocytic leukemia | Juno Therapeutics, Inc.;400 Dexter Avenue North, Suite 1200;Seattle, Washington, 98109 | October 4, 2016 | |
Posaconazole | Invasive aspergillosis | Merck, Sharp & Dohme Corp.;1 Merck Drive;Whitehouse Station, New Jersey, 08889 | October 4, 2016 | |
Atrasentan | Focal segmental glomerulosclerosis | AbbVie Inc.;Regulatory Affairs, 1 North Waukegan Road;North Chicago, Illinois, 60044 | September 29, 2016 | |
Recombinant adeno-associated virus serotype 8 vector encoding human glucose-6-phosphatase-alpha (G6Pase or G6PC) | Von Gierke disease | Dimension Therapeutics;840 Memorial Drive;Cambridge, Massachusetts, 02139 | September 28, 2016 | |
Autologous dendritic cell/tumor antigens | Glioblastoma | China Medical University Hospital;No. 2, Yude Road, North District; | September 27, 2016 | |
Tenofovir disoproxil fumarate | Prevention of mother to child transmission of hepatitis B virus | Gilead Sciences, Inc.;333 Lakeside Drive;Foster City, California, 94404 | September 27, 2016 | |
Wharton’s jelly mesenchymal stem cells | Graft Versus Host Disease | Midwest Stem Cell Therapy Center;University of Kansas Medical Center, 3901 Rainbow Boulevard;Kansas City, Kansas, 66160 | September 27, 2016 | |
Recombinant adeno-associated virus serotype rhesus 74 expressing the human dysferin gene (AAVrh74.MHCK7.DYSF.DV) | Limb-girdle muscular dystrophy- type 2B | Nationwide Children's Hospital;700 Children's Drive, Rm WA2025;Columbus, Ohio, 43205 | September 19, 2016 |